A Phase I Study of GT300 in Healthy Subjects

Summary

Descriptive safety and pharmacokinetics of GT300, exploratory biomarker effects for the evaluation of the effect of GT300 on the autophagy-lysosomal pathway (ALP), food effect on PK and fasting effect on biomarkers.

Timeline

Start

2021-08-23

Primary completion

2022-02-15

Completion

2022-03-15

Drugs

Indications